All Type of News
Court ruling rekindles controversy over handling of oriental medicines
Controversy over oriental medicines has been rekindled as a court ruled that the simple acts of selling oriental drugs did not violate the current Pharmaceutical Affairs Law.
The ruling by the high court in Pusan c...
President Kang Bail-hee of Wyeth Korea retired.
As of Aug. 31, the top executive of Wyeth Korea, Mr. Kang Baik-hee, will retire and continue his advisory role up to the end of this year.
Mr. Kang was born in 1939 and graduated from Yonsei Univ. majoring politica...
FTA talks on pharmaceuticals disclosed
Yakup Shinmoon said it has exclusively made public the contents of ongoing free trade agreement (FTA) talks with the United States on pharmaceuticals and medical equipment.
The contents of the FTA showed the negot...
Review terms for new drug applications to shorten at 5 years.Currently the KFDA's review time for any new drug applications takes about 6 years but the MOHW is now actively considering it to shorten at 5 years.
The MOHW also positively...
|
Koreans work 8 years in one company
Employees of listed companies in Korea work the same job for an average of eight years, which reveals that Korean workers change workplaces more frequently than in the past.
Workers in the pharmaceutical business ...
Appointment of bio equivalency test institutes in trouble.
Recently the court accepted the re-test appeal claimed in the administrative lawsuit raised by 35 pharmaceutical industry against the bio test fraud scandal, but up to now the KFDA has not appointed the test institute...
INT chief to attend ICPM conference
Lim Bee Koong, a general manage in Asia of TNT N.V., the world's leading Business to Business express delivery company, will attend the international conference of pharmaceutical medicine (ICPM) in Seoul from Septembe...
Amodipine to breaks 10-million prescriptions barrier
Hanmi Pharm said its market share of Amodipine (amlodipine camsylate) has been growing quickly, hitting 10 million prescriptions in just two years since its launch on September 2004.
The company plans to publish a ...
Sanofi-Aventis Korea to launch rapid-acting insulin glulisineSanofi-Aventis Korea said it will market Apidra (insulin glulisine) for the treatment of type 1 and type 2 diabetes from next month.
The company said it has added another dia...
|
KFDA to be restructured on Aug. 25.
As of Aug. 25, a draft of the revised working rules on the responsibilities of the KFDA and its affiliates was fixed and promulgated, by which 9 teams will be newly established, 128 personnels will be increased and th...
